[The clinical effect of concomitant use of non-specific immunopotentiator OK-432 on primary lung cancer treated with radiation combined with chemotherapy].
D000328:Adult; D000368:Aged; D001688:Biological Products / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000008:administration & dosage*
D001688:Biological Products; D010844:Picibanil